Mednow Investor Relations Site
  • Home
  • News
  • Media
  • The Team
  • Stock Info
  • Investor Info
    • Financials
    • Governance Docs
    • Research Reports
    • Investor Presentation
  • Investor Contact
Select Page

Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth & 4800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO

by Mednow | Jun 15, 2022 | Press Release

Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth & 4800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO Q3/22 revenue increased over 225% quarter-over-quarter, and more than 4,800% year-over-year;Mednow patient...

Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results

by Mednow | Jun 8, 2022 | Press Release

Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is...

Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors

by Mednow | May 9, 2022 | Press Release

Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors Toronto, ON. (May 9th, 2022) – Mednow Inc. (“Mednow’’ or the “Company”) (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that its common...

Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175%

by Mednow | Apr 26, 2022 | Press Release

Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175% In fiscal Q3 2022, for the 3 months ended April 30, 2022, Mednow is forecasted to have quarterly revenue of C$5 –...

Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More

by Mednow | Apr 18, 2022 | Press Release

Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More April 18, 2022 (Toronto, ON) – Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy,...

Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto

by Mednow | Apr 1, 2022 | Press Release

Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto Toronto, ON. (April 1st, 2022) – Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has completed the acquisition (the...
« Older Entries

Recent Posts

  • Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth & 4800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO
  • Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results
  • Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors
  • Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175%
  • Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More

Recent Comments

    Quick Links

    Executive Management

    Investor FAQs

    Sedar Filings

    Investor Contact

    Benjamin Ferdinand
    ir@mednow.ca
    +1 855 686 6300

    Investor Email Alerts

    Unsubscribe

    © Mednow All Rights Reserved 2021

    Privacy Policy
    Mednow is now trading as MNOW in TSXV